Medication adherence to oral anticancer drugs: systematic review
Authors:
- 16 March 2016
- journal article
- review article
- Published by Taylor & Francis in Expert Review of Anticancer Therapy
- Vol. 16 (4) , 423-432
Abstract
SUMMARYMany studies have demonstrated that non-adherence to oral anticancer drugs (OACDs) has challenged treatment efficacy. Otherwise, few validated tools exist to measure patients’ adherence to medication regimen in clinical practice. To synthesize previous studies on adherence by cancer patients taking OACDs, especially in targeted therapy, a systematic search of several electronic databases was conducted. We analyzed existing scales’ contents for various cancer patients and outcomes of studies assessing adherence. However, a well-validated scale designed particularly for OACD adherence is still lacking. Most adherence scales used in the studies reviewed contain items focused on measuring patients’ medication-taking behavior more than their barriers to medication compliance and beliefs. However, non-adherence to OACDs is a complex phenomenon, and drug-taking barriers and patient beliefs significantly affect patients’ non-adherence. To understand the key drivers and predisposing factors for non-adherenc...Keywords
This publication has 35 references indexed in Scilit:
- Treatment Monitoring Program for Implementation of Adherence to Second-Line Erlotinib for Advanced Non–Small-Cell Lung CancerClinical Lung Cancer, 2013
- Adherence to Tyrosine Kinase Inhibitor Therapy for Chronic Myeloid Leukemia: A Brazilian Single-Center CohortActa Haematologica, 2013
- Feasibility Pilot on Medication Adherence and Knowledge in Ambulatory Patients With Gastrointestinal CancerOncology Nursing Forum, 2012
- Capecitabine non-adherence: Exploration of magnitude, nature and contributing factorsJournal of Oncology Pharmacy Practice, 2012
- Adherence with oral chemotherapy: results from a qualitative study of the behaviour and representations of patients and oncologistsEuropean Journal of Cancer Care, 2010
- Objectively Measured, but Not Self-Reported, Medication Adherence Independently Predicts Event-Free Survival in Patients With Heart FailureJournal of Cardiac Failure, 2008
- Treatment Interruptions and Non-Adherence with Imatinib and Associated Healthcare CostsPharmacoEconomics, 2007
- A meta-analysis of the association between adherence to drug therapy and mortalityBMJ, 2006
- Development and validation of the immunosuppressant therapy adherence instrument (ITAS)Patient Education and Counseling, 2005
- Adherence to MedicationNew England Journal of Medicine, 2005